Kim Jun-Sik, Tanaka Hiroyuki, Shoyama Yukihiro
Department of Pharmacognosy, Faculty of Pharmaceutical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka 812-8582, Japan.
Analyst. 2004 Jan;129(1):87-91. doi: 10.1039/b311304c. Epub 2003 Dec 11.
The monoclonal antibody (MAb) against berberine, a bioactive constituent of Coptis japonica M., Phellodendron amurense R. and Hydrastis canadensis L., was produced and characterized. As immunogen, the derivative of berberine, 9-O-carboxymethyl berberrubine was synthesized and conjugated to carrier protein, bovine serum albumin (BSA). In order to confirm its immunogenicity, the ratio of hapten in berberine-BSA conjugate was determined by matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). After immunization, hybridomas secreting MAbs against berberine were produced by fusing splenocytes with mouse myeloma cell line, P3-X63-Ag8-653. After the screening, anti-berberine MAb 1D5-3B-7 was obtained. Subsequently, a quantitative ELISA system for berberine and its related compounds using the MAb was established and evaluated comparing with HPLC method. The ELISA method described in this study can be available as an analytical tool for quality control and standardization of medicinal plants and its prescriptions containing berberine and its related compounds.
制备并表征了针对黄连、黄柏和北美黄连生物活性成分小檗碱的单克隆抗体(MAb)。作为免疫原,合成了小檗碱的衍生物9 - O - 羧甲基小檗红碱,并将其与载体蛋白牛血清白蛋白(BSA)偶联。为了确认其免疫原性,通过基质辅助激光解吸/电离飞行时间质谱(MALDI - TOF MS)测定了小檗碱 - BSA偶联物中半抗原的比例。免疫后,通过将脾细胞与小鼠骨髓瘤细胞系P3 - X63 - Ag8 - 653融合,产生了分泌抗小檗碱单克隆抗体的杂交瘤。筛选后,获得了抗小檗碱单克隆抗体1D5 - 3B - 7。随后,建立了使用该单克隆抗体的小檗碱及其相关化合物的定量ELISA系统,并与HPLC法进行比较评估。本研究中描述的ELISA方法可作为药用植物及其含有小檗碱及其相关化合物的方剂质量控制和标准化的分析工具。